04.04.2013 Views

Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3.2 Brain Cancer <strong>Stem</strong> <strong>Cells</strong> Introduction<br />

abundant in rat and human glioma cell lines and it specifies a subpopulation<br />

<strong>of</strong> amplifying tumour cells in glioblastoma-like tumours but not in tumours<br />

with oligodendroglioma features, making it a reliable marker to distinguish<br />

oligodendroglioma from glioblastoma. These findings suggest that the ampli-<br />

fying IQGAP1 + cancer cells are closer to a multipotent progenitor cell and<br />

they represent the most aggressive cancer cell population in glioblastoma [39].<br />

In a study by Ma et al [304], the expression <strong>of</strong> the stem cell markers CD133,<br />

Nestin, Sox2 and Musashi-1 amongst others was investigated in 72 astrocy-<br />

tomas <strong>of</strong> different WHO grades to find out that the expression <strong>of</strong> these markers<br />

positively correlated with an increase in the WHO grade <strong>of</strong> the astrocytomas.<br />

Finally, in a very interesting study by Wang et al [520], the stem-cell-like<br />

CD133 + fraction from 14 human glioblastomas was shown to include a subset<br />

<strong>of</strong> vascular endothelial-cadherin (CD144)-expressing cells with characteristics<br />

<strong>of</strong> endothelial progenitors capable <strong>of</strong> maturing into endothelial cells. They<br />

conclude that a subpopulation <strong>of</strong> cells within glioblastoma can give rise to<br />

endothelial cells via a CD133 + /CD144 + endothelial progenitor intermediate<br />

included in the CD133 + cancer stem-cell-like fraction. This discovery opens<br />

up important clinical options since the strong correlation <strong>of</strong> tumour grade and<br />

neoplastic vasculature in human gliomas indicates that agents blocking the en-<br />

dothelial transition <strong>of</strong> tumour cells may provide a novel therapeutic strategy.<br />

Recognition <strong>of</strong> the forebrain SVZ astrocytes as the descendants <strong>of</strong> radial glia in<br />

the adult brain and their capacity to act as NS cells in vitro raises the prospect<br />

that this cell type might be responsible for tumour expansion, identifying it-<br />

self with the cancer stem cell population <strong>of</strong> the cancer stem cell hypothesis.<br />

Therefore, although it is not yet clear whether cancer-initiating events occur<br />

in NS cells, progenitors or differentiated cells, NS cells are attractive candi-<br />

dates. Their self-renewal abilities would allow an oncogene to more easily<br />

initiate uncontrolled proliferation, and their potential for transformation has<br />

been further considered based on the observations that human brain tumours<br />

frequently arise deep in the brain near the SVZ. In p53 -/- mice, more prolifer-<br />

ative activity is found in the SVZ and more neurospheres can be isolated from<br />

this region, suggesting an expansion <strong>of</strong> the NS cell pool, which may make the<br />

area more susceptible to neoplastic transformation [122]. Moreover, normal NS<br />

cells were found in the CD133 + population <strong>of</strong> the normal human fetal brain,<br />

again suggesting that the cell <strong>of</strong> origin <strong>of</strong> brain tumours may be a normal NS<br />

71

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!